Repeated administration of imipramine attenuates glutamatergic transmission in rat frontal cortex
Abstract
The effects of repeated administration of a tricyclic antidepressant, imipramine, lasting 14 days (10 mg/kg p.o., twice daily), were studied ex vivo in rat frontal cortex slices prepared 48 h after last dose of the drug. In slices prepared from imipramine-treated animals the mean frequency, and to a lesser degree the mean amplitude, of spontaneous excitatory postsynaptic currents recorded from layer II/III pyramidal neurons, were decreased. These effects were accompanied by a reduction of the initial slope ratio of pharmacologically isolated N-methyl-D-aspartate to AMPA/kainate receptor-mediated stimulation-evoked excitatory postsynaptic currents. Imipramine treatment also resulted in a decrease of extracellular field potentials evoked in layer II/III by stimulation of underlying sites in layer V. These results indicate that chronic treatment with imipramine results in an attenuation of the release of glutamate and an alteration in the postsynaptic reactivity of ionotropic glutamate receptors in rat cerebral cortex.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Antidepressants are believed to exert one of their therapeutic effects by modulating the extracellular availability of glutamate.
“Interestingly, antidepressants are believed to exert one of the therapeutic effects by modulating the extracellular availability of this neurotransmitter [122,123,124,125].”
From P2X7 Receptor Signaling in Stress and Depression (2019) · cites this paper as [125]
The citation lists haven’t been fetched yet
References 52 · Cited by 65
- Authors
- Tokarski, K., Bobula, B., Wabno, J., & Hess, G.
- Affiliations
- Maj Institute of Pharmacology (PL)
- Jagiellonian University (PL)
- Corresponding author
- Hess, G.
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 2008-05
- Volume
- 153
- Issue
- 3
- Pages
- 789-795
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2087467518
- Cited by
- 65
- References
- 52
- Citations by year
- 2026: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 4 · 2019: 4 · 2018: 1 · 2017: 2 · 2016: 3 · 2015: 5 · 2014: 5 · 2013: 4 · 2012: 9
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- imipramine, chronic antidepressant treatment, glutamatergic neurotransmission, frontal cortex, excitatory postsynaptic currents, NMDA receptor, non-NMDA receptors, ionotropic glutamate receptors, glutamate release, pyramidal neurons, field potentials, tricyclic antidepressants
- MeSH terms
- Animals, Antidepressive Agents, Tricyclic, Frontal Lobe, Imipramine, Male, Synaptic Transmission, Organ Culture Techniques, Receptors, N-Methyl-D-Aspartate, Rats, Wistar, Receptors, AMPA, Patch-Clamp Techniques, Glutamic Acid, Excitatory Postsynaptic Potentials, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review